1996年以降のもののみ掲載.各論文のAbstract(Entrez-PubMed収載分)にリンクしています

後藤 敏 全件表示
Akira Hiramatsu, Bin Gotoh, Yutaka Fujii, Tetsuya Yoshida, Kazuaki Chayama, and Takemasa Sakaguchi. Suppression of interferon-related promoter activation by hepatitis C virus proteins expressed in cultured cells. Hiroshima Journal of Medical Sciences, 55(3), 71-77, 2006
Takayuki Komatsu, Kenji Takeuchi, Junko Yokoo, and Bin Gotoh: C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-β production. Virology, 325, 137-148, 2004
Bin Gotoh, Kenji Takeuchi, and Takayuki Komatsu: Inhibition of the gamma interferon response by a Sendai virus C protein mutant with no STAT1-binding ability. FEBS Letters, 567, 291-296, 2004
Bin Gotoh, Takayuki Komatsu, Kenji Takeuchi, and Takayuki Komatsu: The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology, 316, 29-40, 2003
Bin Gotoh, Kenji Takeuchi, Takayuki Komatsu, and Junko Yokoo: The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. Journal of Virology, 77, 3360-3370, 2003
Takayuki Komatsu, Kenji Takeuchi, Junko Yokoo and Bin Gotoh: Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Letters, 511, 139-144, 2002
Bin Gotoh, Takayuki Komatsu, Kenji Takeuchi and Junko Yokoo. Paramyxovirus strategies for evading the interferon response. Reviews in Medical Virology 12, 337-357, 2002
Bin Gotoh, Takayuki Komatsu, Kenji Takeuchi and Junko Yokoo. Paramyxovirus accessory proteins as interferon antagonists. Microbiology and Immunology 45(12), 787-800, 2001
Kenji Takeuchi, Takayuki Komatsu, Junko Yokoo, Atsushi Kato, Tatsuo Shioda, Yoshiyuki Nagai and Bin Gotoh: Sendai virus C protein physically associates with Stat1. Genes to Cells, 6, 545-557、2001
Takayuki Komatsu, Kenji Takeuchi, Junko Yokoo, Yukie Tanaka and Bin Gotoh: Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. Journal of Virology, 74, 2477-2480, 2000
Bin Gotoh, Kenji Takeuchi, Takayuki Komatsu, Junko Yokoo, Yoshinobu Kimura, Atsushi Kurotani, Atsushi Kato and Yoshiyuki Nagai: Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses. FEBS Letters, 459, 205 -210, 1999
Junko Yokoo, Bin Gotoh, Takayuki Komatsu, Kenji Takeuchi and Toshiaki Miyadai: Replication-incompetent Sendai virus can suppress the antiviral action of type I interferon. Archives of Virology, 144, 1043-1055, 1999


井上 寛一 全件表示
Kim, C. J., Tambe, Y., Munkaisho, K., Sugihara, H., Isono, T., Sonoda, H., Shimizu, T., Kondoh, G., Inoue, H. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice. Carcinogenesis, 35, 227-236 2014.
Tambe, Y., Okuyama, N., Nakagawa, T., Muramoto, A., Hasebe, M., and Inoue, H. Suppression of viral replication by drs tumor suppressor via mTOR dependent pathway. Cancer Letters 314, 82-91, 2012
Kim, C. J., Sakamoto, K., Tambe, Y., and Inoue, H. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int. J. Oncol. 38, 1759-1766, 2011.
Chano, T., Ikebuchi, K., Tomita, Y., Jin, Y., Inaji, H., Ishitobi, M., Teramoto, K., Ochi, Y., Tameno, H., Nishimura, I., Minami, K., Inoue, H., Isono, T., Saitoh, M., Shimada, T., Hisa, Y., Okabe, H. RBCC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients. PLos ONE 5, e15737,2010.
Chano, T., Ikebuchi, K., Ochi, Y., Tameno, H., Tomita, Y., Jin, Y., Inaji, H., Ishitobi, M., Teramoto, K., Nishimura, I., Minami, K., Inoue, H., Isono, T., Saitoh, M., Shimada, T., Hisa, Y., Okabe, H. RBCC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. PLos ONE 5, e11404, 2010.
Isono, T., Kim, C. J., Ando, Y., Sakurai, H., Okada, Y., and Inoue, H. Suppression of cell invasiveness by periostin via TAB1/TAK1. Int. J. Oncol., 35, 425-432, 2009.
Tambe, Y., Yamamoto, A., Isono, T., Chano, T., Fukuda, M. and Inoue, H. (2009) The Drs tumor suppressor is involved in the maturation process of autophagy induced by low serum. Cancer Letters, 2009 Apr 13. [Epub ahead of print]
Kim, C. J., Nishi, K., Isono, T., Okuyama, Y., Tambe, Y., Okada, Y., and Inoue, H. (2009) Cyclin D1b variant prpmotes cell invasiveness independent of binding to CDK in human bladder cancer cells. Mol. Carcinog., 2009 May 4. [Epub ahead of print]
Shimakage, M., Kodama, K., Kawahara, K., Kim, C. J., Ikeda, Y., Yutsudo, M., and Inoue, H. (2009) Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors. Oncol. Rep. 21, 1367-1372, 2009.
Nishi, K., Inoue, H., Schnier, J. B., and Rice, R. H.  Cyclin D1 downregulation isimportant for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J. Cell Biochem. 106, 63-72, 2009.
Kim, C. J., Isono, T., Tambe, Y., Chano, T., Okabe, H., Okada, Y. and Inoue, H.  Role of alternative splicing of periostin in human bladder carcinogenesis. Int. J. Oncol. 32, 161-169, 2008.
Minami, K., Tambe, Y., Watanabe, R., Isono, T., Haneda, M., Isobe, K., Kobayashi, K., Hino, O., Okabe, H., Chano, T., Inoue, H. Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway.J. Virol. 81, 11106-11115, 2007.
Minami, K., Inoue, H., Terashita, T., Kawakami, T., Watanabe, R., Haneda, M., Isobe, K., Okabe, H. and Chano, T.  GADD34 induces p21 expression and cellular senescence. Oncol. Rep., 7, 1481-1485, 2007
Shimakage, M., Inoue, N., Oshima,K., Kawahara, K., Yamamoto, N., Oka, T., Tambe, Y.,Yasui, K., Matsumoto, K., Yutsudo, M., and Inoue, H.  Down-regulation of drs mRNA is associated with the progression of adult T-cell leukemia/lymphoma. Int. J. Oncol. 30, 1343-1348, 2007.
Watanabe, R., Tambe,Y., Inoue, H., Isono, T., Haneda, M., Isobe, K., Kobayashi. T., Hino, O., Okabe, H. and Chano, T. GADD34 inhibits mammalian target of rapamycin signaling survival under bioenergetic stress. Int. J. Mol. Med., 19, 475-483, 2007
Tambe, Y., Yoshioka-Yamashita, A., Mukaisho, K., Haraguchi, S., Chano, T., Isono, T., Kawai, T., Suzuki, Y., Kushima,R., Hattori, T., Goto, M., Yamada, S., Kiso, M., Saga, Y. and Inoue, H. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs. Carcinogenesis, 28, 777-784, 2007
Kageyama, S., Iwaki, H., Inoue, H., Isono, T., Yuasa, T., Nogawa, M., Maekawa, T., Ueda, M., Kajita, Y., Ogawa, O., Toguchida, J. and Yoshiki, T. A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma. Proteomics Clin. Appl. 1, 192-199, 2007.
Chano, T,, Saji, M., Inoue, H., Minami, K., Kobayashi, T., Hino, O. and Okabe, H. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation. Int. J. Mol. Med. 18: 425-432, 2006
Shimakage, M., Inoue, N., Oshima, K., Kawahara, K., Oka, T., Yasui, K., Matsumoto, K., Inoue, H., Watari, A., Higashiyama, S. and Yutsudo, M. Down-regulation of ASY/Nogo Transcription associated with progression of adult T-cell leukemia/lymphoma. Int. J. Cancer 119: 1648-1653, 2006.
Kim, C. J., Yoshioka, N., Tambe, Y., Kushima, R., Okada, Y., and Inoue, H. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int. J. Cancer 117: 51-58, 2005.
Watanabe, R., Chano, T., Inoue, H., Isono, T., Koiwai, O., Okabe, H. Rb1cc1 is critical for myoblast differentiation through Rb1 regulation. Virchows Arch 446: 643-648, 2005.
Suzuki, J., Sukezane, T., Akagi, T., Georgescu, M. M., Ohtani, M., Inoue, H., Jat, P. S., Goff, S., Hanafusa, H., and Shishido, T.: The loss of c-abl facilitates anchorage independent growth of primary mouse embryonic fibroblasts in combination with the loss of functions of p53 and RB. Oncogene, 23, 8527-8534, 2004
Tambe, Y., Isono, T., Haraguchi, S., Yoshioka, A., Yutsudo, M., and Inoue, H.: A Novel Apoptotic Pathway Induced by the drs Tumor Suppressor Gene. Oncogene 23, 2977-2987, 2004.
Haraguchi, S., Saga, Y., Naito, K., Inoue, H., and Seto, A. Specific gene silencing in the pre-implantation stage mouse embryo by an siRNA expression vector system. Mol. Reprod. Dev., 68, 17-24, 2004.
Shimakage, M., Kawahara, K., Sasagawa, T., Inoue, H., Yutsudo, M., Yoshida, M., and Yanoma, S. Expression of Epstein−Barr virus in thyroid carcinoma correlates with tumor progression. Human Pathology, 34, 1170-1177, 2003.
Kim, C. J., Shimakage, M., Kushima, R., Mukaisho, K., Shinka, T., Okada, Y. and Inoue, H. Down-regulation of drs mRNA in human prostate carcinomas. Human Pathology, 34, 654-657, 2003.
Qi, B., Qi, Y., Watari, A., Yoshioka, N., Inoue, H., Minemoto, Y., Yamashita, K., Sasagawa, T. and Yutsudo, M. Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. Journal of Cellular Physiology, 196, 312-318, 2003.
Yoshioka, N., Fuji, S., Shimakage, M., Kodama, K., Hakura, A., Yutsudo, M., Inoue, H. and Nojima, H. : Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp. Cell Res. 279, 91-99, 2002.
Mukaisho, K., Suo, M., Shimakage, M., Kushima, R., Inoue, H. and Hattori, T. : Down-regulation of drs mRNA in colorectal neoplasms. Jap. J. Cancer Res. 93, 888-893, 2002.
Shimakage, M., Takami, K., Kodama, K, Mano, M., Yutsudo, M. and Inoue, H. : Expression of drs mRNA in human lung adenocarcinomas. Human Pathology 33, 615-619, 2002.
Kawai, T., Suzuki, Y., Yamashita, A., and Inoue, H. : Isolation of a novel mouse variant of the drs tumor suppressor gene. Cancer Letters 183, 79-86, 2002.
Li, Q., Oka, K., Shimakage, M., Yoshioka, N., Kodama, K., Inoue, H., Hakura, A., Stanbridge, E.J., and Yutsudo, M. : Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 20, 3929-3936, 2001.
Shimakage M, Kawahara K, Kikkawa N, Sasagawa T, Yutsudo M, Inoue H : Downregulation od drs mRNA in human colon adenocarcinomas. Int.J.Cancer 87 : 5 - 11, 2000.
Yoshioka N, Inoue H, Nakanishi K, Oka K, Yutsudo M, Yamashita A, Hakura A, Nojima H : Isolation of transformation suppressor genes by cDNA subtraction: Lumican suppresses transformation induced by v-src and v-K-ras. J. Virol. 74 : 1008 - 1013, 2000.
Yamashita A, Hakura A, Inoue H : Suppression of anchorage-independent growth of human cancer cell lines by the drs gene. Oncogene 18 : 4777 - 4787, 1999.
Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, Inoue M : Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int. J. Cancer 80 : 804 - 809, 1999.
Inoue H, Pan J, Hakura A : Suppression of v-Src transformation by the drs gene. J. Virol. 72 : 2532- 2537, 1998.
Ishiwatari H, Nakanishi K, Kondoh G, Hayasaka N, Li Q, Yamashita A, Inoue H, Hakura A : Suppression of tumor growth by the 3' untranslated region of mel-18 in 3Y1 cells transformed by the E6 and E7 genes of human papillomavirus type 18. Cancer letters 117 : 57 - 65, 1997.
Matsumoto K, Fujisawa J, Inoue H, Hakura A, Shibata H, Fujii M : Human T-cell leukemia virus type I tax protein transforms rat fibroblasts via two distinctive pathways. J. Virol. 71 : 4445 - 4451, 1997.
Tang G, Iida T, Inoue H, Yutsudo M, Yamamoto K, Honda T : A mutant cell line resistant to Vibrio parahaemolyticus thermostable direct hemolysin (TDH): its potential in identification of putative receptor for TDH. Biochim. Biophys. Acta 1360 : 277 - 282, 1997.
Tavoloni N, Inoue H: Cellular aging is a critical determinant of primary cell resistance to v-Src transformation. J. Virol. 71 : 237 - 247, 1997.
Inoue H, Yamashita A, Hakura, A : Adhesion-dependency of serum-induced p42/p44 MAP kinase activation is released by retroviral oncogenes. Virology 225 : 223 - 226, 1996.
Shimakage M, Miyata Y, Inoue H, Yutsudo M, Hakura A : Increased sensitivity of EBNA2-transformd rat fibroblasts to ionizing radiation. Int. J. Cancer 68 : 612 - 615, 1996.
Pan J, Nakanishi K, Yutsudo M, Inoue H, Li Q, Oka K, Yoshioka N, Hakura A : Isolation of a novel gene down-regulated by v-src. FEBS letters 383 : 21 - 25, 1996.


旦部 幸博 全件表示
Tambe, Y., Kim, C. J., Munkaisho, K., Sugihara, H., Isono, T., Sonoda, H., Shimizu, T., Kondoh, G., Inoue, H. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice. Carcinogenesis, 35, 227-236 2014.
Tambe, Y., Okuyama, N., Nakagawa, T., Muramoto, A., Hasebe, M., and Inoue, H. Suppression of viral replication by drs tumor suppressor via mTOR dependent pathway. Cancer Letters 314, 82-91, 2012
Kim, C. J., Sakamoto, K., Tambe, Y., and Inoue, H. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int. J. Oncol. 38, 1759-1766, 2011.
Tambe, Y., Yamamoto, A., Isono, T., Chano, T., Fukuda, M. and Inoue, H. (2009) The Drs tumor suppressor is involved in the maturation process of autophagy induced by low serum. Cancer Letters, 2009 Apr 13. [Epub ahead of print]
Kim, C. J., Nishi, K., Isono, T., Okuyama, Y., Tambe, Y., Okada, Y., and Inoue, H. (2009) Cyclin D1b variant prpmotes cell invasiveness independent of binding to CDK in human bladder cancer cells. Mol. Carcinog., 2009 May 4. [Epub ahead of print]
Kim, C. J., Isono, T., Tambe, Y., Chano, T., Okabe, H., Okada, Y. and Inoue, H.  Role of alternative splicing of periostin in human bladder carcinogenesis. Int. J. Oncol. 32, 161-169, 2008.
Minami, K., Tambe, Y., Watanabe, R., Isono, T., Haneda, M., Isobe, K., Kobayashi, K., Hino, O., Okabe, H., Chano, T., Inoue, H. Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway.J. Virol. 81, 11106-11115, 2007.
Shimakage, M., Inoue, N., Oshima,K., Kawahara, K., Yamamoto, N., Oka, T., Tambe, Y.,Yasui, K., Matsumoto, K., Yutsudo, M., and Inoue, H.  Down-regulation of drs mRNA is associated with the progression of adult T-cell leukemia/lymphoma. Int. J. Oncol. 30, 1343-1348, 2007.
Watanabe, R., Tambe,Y., Inoue, H., Isono, T., Haneda, M., Isobe, K., Kobayashi. T., Hino, O., Okabe, H. and Chano, T. GADD34 inhibits mammalian target of rapamycin signaling survival under bioenergetic stress. Int. J. Mol. Med., 19, 475-483, 2007
Tambe, Y., Yoshioka-Yamashita, A., Mukaisho, K., Haraguchi, S., Chano, T., Isono, T., Kawai, T., Suzuki, Y., Kushima,R., Hattori, T., Goto, M., Yamada, S., Kiso, M., Saga, Y. and Inoue, H. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs. Carcinogenesis, 28, 777-784, 2007
Kim, C. J., Yoshioka, N., Tambe, Y., Kushima, R., Okada, Y., and Inoue, H. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int. J. Cancer 117: 51-58, 2005.
Tambe, Y., Isono, T., Haraguchi, S., Yoshioka, A., Yutsudo, M., and Inoue, H.: A Novel Apoptotic Pathway Induced by the drs Tumor Suppressor Gene. Oncogene 23, 2977-2987, 2004.
Shigeo Tanaka, Yoichi Sakata, Katsushi Morimoto, Yukihiro Tambe, Yoshihiko Watanabe, Gisho Honda, Mamoru Tabata, Tikashi Oshima, Toru Masuda, Toshiaki Umezawa, Mikio Shimada, Naotaka Nagakura, Wasuke Kamisako, Yoshiki Kashiwada and Yasumasa Ikeshiro.Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1. Planta Med. 67:108-113, 2001.
Yukihiro Tambe,Hitomi Tsujiuchi, Gisho Honda, Yasumasa Ikeshiro and Shigeo Tanaka. . Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, b-caryophyllene. Planta Medica. 62. 469-470.1996.
Shigeo Tanaka, Makoto Akimoto, Yukihiro Tambe, Mamoru Tabata and Yasumasa Ikeshiro. Volatile antiallergic principles from a traditional herbal prescription of Kampo medicine. Phytotherapy Research, 10 :238-241.1996


北川 善紀 全件表示
(作成中)




BORDER

[TOP][研究概要] [研究テーマ][大学院生・研究生募集][研究室セミナー]
BORDER